Showing results (1261-1270 of 12,832) with videos related to
Sort By:
Pageof 1,284
ACS Omega|August 29, 2019
Extent of Helical Induction Caused by Introducing α-Aminoisobutyric Acid into an Oligovaline SequenceGenichiro Tsuji, Takashi Misawa, Mitsunobu Doi, et al.Bio-Protocol|March 4, 2021
Self-organization Assay for Min Proteins of Escherichia coli in Micro-droplets Covered with LipidsShunshi Kohyama, Kei Fujiwara, Natsuhiko Yoshinaga, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 10, 2022
An early return-to-work program for COVID-19 close contacts in healthcare during the Omicron wave in JapanHiroyuki Naruse, Yohei Doi, Mitsunaga Iwata, et al.JBJS Case Connector|September 5, 2025
A 26-Year Follow-up of Double Free Muscle Transfer Reconstruction for Total Brachial Plexus Injury: A Case ReportKazuteru Doi, Yasunori Hattori, Sotetsu Sakamoto, et al.Nanoscale|May 28, 2020
Conformational equilibrium of MinE regulates the allowable concentration ranges of a protein wave for cell divisionShunshi Kohyama, Kei Fujiwara, Natsuhiko Yoshinaga, et al.Japanese Circulation Journal|March 1, 1987
Recent morbidity trends in myocardial infarction in Japan: investigation of death certificates and the survival rates at coronary care unitsT Shimamoto, H Inada, M Doi, et al.The Journal of Chemical Physics|May 17, 2020
Gel dynamics in the mixture of low and high viscosity solvents: Re-entrant volume change induced by dynamical asymmetryYoshimi Tanaka, Miyu Seii, Jize Sui, et al.Microbiology and Immunology|May 21, 2015
Viral protein R of HIV type-1 induces retrotransposition and upregulates glutamate synthesis by the signal transducer and activator of transcription 1 signaling pathwayAkihiro Doi, Kenta Iijima, Shigeyuki Kano, et al.Plos One|August 12, 2021
Socially responsible investing through the equity funds in the global ownership networkTakayuki Mizuno, Shohei Doi, Takahiro Tsuchiya, et al.Acta Crystallographica. Section B, Structural Science|July 20, 2004
Rigid backbone moiety of KNI-272, a highly selective HIV protease inhibitor: methanol, acetone and dimethylsulfoxide solvated forms of 3-[3-benzyl-2-hydroxy-9-(isoquinolin-5-yloxy)-6-methylsulfanylmethyl-5,8-dioxo-4,7-diazanonanoyl]-N-tert-butyl-1,3-thiazolidine-4-carboxamideMitsunobu Doi, Tooru Kimura, Toshimasa Ishida, et al.Pageof 1,284